Phase II study of intravenous bolus recombinant interleukin-2 in advanced malignant melanoma: Southwest oncology group study

Robert P. Whitehead, Kenneth J. Kopecky, Michael K. Samson, John J. Constanzi, Ronald B. Natale, Lynn G. Feun, Evan M. Hersh, John J. Rinehart

Research output: Contribution to journalArticle

39 Scopus citations
Original languageEnglish (US)
Pages (from-to)1250-1252
Number of pages3
JournalJournal of the National Cancer Institute
Volume83
Issue number17
DOIs
StatePublished - Sep 4 1991
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Whitehead, R. P., Kopecky, K. J., Samson, M. K., Constanzi, J. J., Natale, R. B., Feun, L. G., Hersh, E. M., & Rinehart, J. J. (1991). Phase II study of intravenous bolus recombinant interleukin-2 in advanced malignant melanoma: Southwest oncology group study. Journal of the National Cancer Institute, 83(17), 1250-1252. https://doi.org/10.1093/jnci/83.17.1250